Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dainippon Sumitomo Pharma patents DPP IV inhibitors for diabetes

Aug. 31, 2009

French scientists disclose bisphosphonate-based vectors for targeting bone tissue

Aug. 31, 2009

Novel GlaxoSmithKline agents activate SIRT1

Aug. 31, 2009

Lactam inhibitors of 11-beta-HSD1 presented by Vitae Pharmaceuticals

Aug. 28, 2009

Endo to partner with ProStrakan to commercialize Fortesta in the U.S.

Aug. 28, 2009

Diamyd to include children and accelerate recruitment in phase III diabetes trial

Aug. 28, 2009

Protalix receives FDA fast track designation for prGCD for Gaucher's disease

Aug. 27, 2009

Johnson & Johnson develops DGAT1 inhibitors for treating the metabolic syndrome

Aug. 27, 2009

Bayer Schering Pharma claims novel MR antagonists, PR and AR agonists

Aug. 26, 2009

Preclinical characteristics of antidiabetic candidate canagliflozin described

Aug. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...